Carregant...
Thrombotic events following tocilizumab therapy in critically ill COVID-19 patients: a Façade for prognostic markers
BACKGROUND: Hospitals in the Middle East Gulf region have experienced an influx of COVID-19 patients to their medical wards and intensive care units. The hypercoagulability of these patients has been widely reported on a global scale. However, many of the experimental treatments used to manage the v...
Guardat en:
| Publicat a: | Thromb J |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479301/ https://ncbi.nlm.nih.gov/pubmed/32922212 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12959-020-00236-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|